The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points

Background: Cardiac resynchronisation is a promising new intervention for patients with heart failure, left ventricular systolic dysfunction and ventricular dyssynchrony. Objective: The CARE-HF trial is designed to evaluate the long-term effects of cardiac (atrio-bi-ventricular) resynchronisation on...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of heart failure 2001-08, Vol.3 (4), p.481-489
Hauptverfasser:	Cleland, J.G.F., Daubert, J.C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., Klein, W., Tavazzi, L.
Format:	Artikel
Sprache:	eng
Schlagworte:	ACE inhibitors Adrenergic beta-Antagonists - administration & dosage Angiotensin-Converting Enzyme Inhibitors - administration & dosage beta-blockers cardiac (atrio-bi-ventricular) resynchronisation cardiac dyssynchrony CARE-HF trial Cause of Death Echocardiography Electrocardiography Female Heart Failure - diagnosis Heart Failure - mortality Heart Failure - therapy Heart-Assist Devices Humans Male Prognosis Proportional Hazards Models Reference Values Sensitivity and Specificity Severity of Illness Index Survival Analysis Treatment Outcome United Kingdom Ventricular Dysfunction, Left - diagnosis Ventricular Dysfunction, Left - mortality Ventricular Dysfunction, Left - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!